Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
Eva-Maria Hametner, Klaus Seppi, Werner PoeweDepartment of Neurology, Innsbruck Medical University, Innsbruck, AustriaAbstract: The aim of this article is to provide a short review of the most relevant pharmacological and clinical data on pramipexole extended release (ER) as well as to address the c...
Main Authors: | Hametner EM, Seppi K, Poewe W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | Clinical Interventions in Aging |
Subjects: | |
Online Access: | https://www.dovepress.com/role-and-clinical-utility-of-pramipexole-extended-release-in-the-treat-peer-reviewed-article-CIA |
Similar Items
-
USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01) -
USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01) -
Analysis of pramipexole dose–response relationships in Parkinson's disease
by: Wang Y, et al.
Published: (2016-12-01) -
Sustained-release pramipexole in the treatment of Parkinson’s disease
by: Natalia Vladimirovna Fedorova
Published: (2012-03-01) -
Switch from Immediate-release Pramipexole to Extended-release Pramipexole: The Safety and Efficacy Characteristics of Sixty-eight Patients
by: Müge Kuzu, et al.
Published: (2016-09-01)